Acta Neuropathologica CommunicationsNeurosciencePeer-reviewed journal article
Telomere-induced senescence increases aberrant intraneuronal amyloid-β accumulation by impairing autophagy in a mouse model of Alzheimer's disease
Núria SuelvesiD, Shirine SalekiiD, Tasha IbrahimiD, Debora PalomaresiD, Sebastiaan MooneniD, Marta J. KoperiD, Céline VrancxiD, Devkee M. VadukuliD, Nicolas PapadopoulosiD, Nikenza ViceconteiD, Eloïse ClaudeiD, Rik R. VandenbergheiD, Christine A. F. Von ArnimiD, Stefan N. ConstantinescuiD, Dietmar Rudolf ThaliD, Anabelle DecottigniesiD, Pascal Kienlen‐CampardiD
Abstract
Aging is a well-known risk factor for Alzheimers disease (AD) and other neurodegenerative pathologies, but the molecular and cellular changes occurring in the aging brain are poorly understood. AD pathology seems to correlate with the appearance of cells that become senescent due to the progressive accumulation of cellular insults causing DNA damage. In this study, we investigated the role of cellular senescence on AD pathology by crossing an amyloid-{beta} (A{beta}) mouse model of AD (5xFAD) with a mouse model of senescence that is genetically deficient for the RNA component of the telomerase (Terc-/-). Our results show that accelerated senescence reduces amyloid plaque formation and A{beta} levels at an age when full-blown amyloid pathology is observed in 5xFAD mice. However, early and aberrant intraneuronal A{beta} accumulation is observed in the subiculum and cortical layer V of senescent mice. Selective neurodegeneration linked to telomere attrition and early intraneuronal A{beta} accumulation was observed in these particular regions. Finally, our results suggest that the effect of senescence on amyloid pathology might be mediated through an alteration in autophagy function. Altogether, these findings demonstrate the instrumental role of senescence in intraneuronal A{beta} accumulation associated to AD pathophysiology, and further support future approaches targeting these processes for therapeutic intervention.
- Citations
- 43
- FWCI
- 7.60
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Astrocyte senescence in an Alzheimer’s disease mouse model is mediated by TGF-β1 and results in neurotoxicity
Shoshik Amram, Tal Iram, … Dan Frenkel·bioRxiv·Jul 12, 2019
- Telomere-driven senescence accelerates tau pathology, neuroinflammation and neurodegeneration in a tauopathy mouse model
Debora Palomares, Axelle Vanparys, … Núria Suelves·Acta Neuropathologica CommunicationsPeer-reviewed·Sep 29, 2025
- Ageing-associated myelin dysfunction drives amyloid deposition in mouse models of Alzheimer's disease
Constanze Depp, Ting Sun, … Klaus‐Armin Nave·NaturePeer-reviewed·May 31, 2023
- APPNL-F knock-in Alzheimer's Disease model mice reveal etiological convergence of aging and amyloidosis
Matthieu Prieur, Anne-Laure Hemonnot-Girard, … Hélène Hirbec·bioRxiv·Jan 31, 2026
- DNA damage drives a unique, Alzheimer's disease-relevant senescent state in neurons
Jun‐Wei B. Hughes, Anja Sandholm, … Judith Campisi·bioRxiv·Apr 3, 2026
- Δ133p53α Protects Human Astrocytes from Amyloid-Beta Induced Senescence and Neurotoxicity
Kyra Ungerleider, Jessica A. Beck, … Curtis C. Harris·bioRxiv·May 17, 2021